Hall Private Wealth Advisors Abb Vie Inc. Transaction History

Hall Private Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$144.61 - $166.54 $1.71 Million - $1.97 Million	-11,821 Reduced 18.76%	51,190 $8.16 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $461,678 - $553,674	-3,338 Reduced 5.03%	63,011 $0
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $643,939 - $738,556	4,798 Added 7.8%	66,349 $8.91 Million
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $1.65 Million - $2.1 Million	-12,000 Reduced 16.32%	61,551 $9.43 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $49,492 - $61,406	375 Added 0.51%	73,551 $11.9 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $670,685 - $848,610	6,243 Added 9.33%	73,176 $9.91 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $5.55 Million - $6.31 Million	52,203 Added 354.4%	66,933 $7.22 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.55 Million - $1.73 Million	14,730 New	14,730 $1.66 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Hall Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Hall Private Wealth Advisors with notifications on news.